Search
for
Sort by
Research 181–210 of 1000+
- Management of Hair Loss
- Scalp Reduction as an Adjunct to Hair Transplantation: Review of Relevant Literature and Presentation of an Improved Technique
- Modern hair restoration surgery
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Cryopreservation of Hair Follicles at -20C°: Can It Work in Staged Hair Transplantation
- The efficacy of topical minoxidil 2% versus topical botanically derived inhibitors of 5 alpha reductase in treatment of female pattern hair loss by trichoscopy
- Óleo essencial de alecrim (Salvia rosmarinus) no crescimento capilar associando o alta frequência e massagem epicrânia
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- Estudio sobre la pérdida de cabello y las prácticas de cuidado entre los estudiantes de la Universidad de Manizales, Manizales (Colombia), 2016
- Assessment of Human Nuclear Factor Erythroid 2 Related Factor 2 (NRF2) in Androgenetic Alopecia in Egyptian Men
- Figure 8, The Hamilton-Norwood classification of male androgenetic Alopecia
- Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia
- Cutaneous signs in COVID ‐19 patients: A review
- Susceptibility variants for male-pattern baldness on chromosome 20p11
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- Prevalence of Androgenetic Alopecia Among Adults in Sulaimani Governorate (2023): Epidemiology, Pathophysiology, and Clinical Implications
- Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases
- Association of androgenetic alopecia and severity of coronavirus disease 2019
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Hubungan andropause dengan alopesia androgenik pada aparatur sipil negara di Pusat Pemerintahan Kabupaten Badung tahun 2022
- The Life and Legacy of O'Tar T. Norwood: A Founding Father of the Norwood-Hamilton Classification System for Male Pattern Baldness, the <i>Forum</i>, and the ISHRS
- Pioneer of the Month: O’Tar T. Norwood, MD
- A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata
- N‑K SCIENCES IN 13 MONTHS: The Complete Bibliography — 335+ Publications Organized by Scientific Domain (February 2025 – March 2026)